Topic: Dexa Scan

The "cash pay" healthcare model is presented as the only way to access advanced diagnostic tools like DEXA scans, VO2 Max testing, and pharmacogenetic screenings. These tests allow clinicians to see how a patient's unique genome metabolizes drugs and identify visceral fat risks before they manifest as chronic illness. Bueller argues that because insurance companies refuse to cover these predictive tools, patients must take sovereignty over their own health data.

Ways to Well utilizes advanced diagnostic tools such as DEXA scans, VO2 Max testing, and pharmacogenetic screenings to assess patient health at the biological level. These tests allow clinicians to identify risks for heart attack and stroke decades before symptoms manifest. Pharmacogenetic testing specifically identifies how a patient's genome metabolizes drugs, revealing that a significant percentage of the population cannot effectively absorb certain medications like opioids.